The Medicine Maker | The Medicine Maker

In Vivo CAR T: A New Route to Treating Autoimmune Disease

July 13, 2026

How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments

6 min read

FDA Selects Seven Companies for Drug Manufacturing Pilot

Selected companies will receive earlier FDA engagement to support new US drug manufacturing facilities across small molecules, biologics, sterile injectables, and advanced therapies

Research News

This Week’s CGT News: Radiopharmaceutical Boosts CAR T

A targeted radiopharmaceutical improves CAR T activity in neuroblastoma models, engineered Tregs suppress allergic asthma, and new gene therapy platforms target MMA and the brain

Outsourcing

Biopharma Vital Signs – Part 4: The New Partnership Playbook

Experts discuss how biopharma partnerships are evolving, as companies look beyond transactional supplier relationships toward more integrated, strategic, and collaborative models

Cell & Gene

Inside the Rise of circRNA

Circio CEO Erik Wiklund reflects on the discovery of human circular RNA and its evolution into a fast-moving therapeutic modality

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Christine Allen

Professor, University of Toronto; Co-founder and CEO, Intrepid Labs

View Profile

Hanns-Christian Mahler

CEO (Chief Enablement Officer) & Board Member, ten23 health

View Profile

FOYA: Celebrating Innovation in Pharma Facilities

We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.

Read the article

All the latest Medicine Maker articles.

Drug Discovery Interviews Business & Trends

Are Researchers Learning to Trust AI?

July 8, 2026

Elsevier’s Mirit Eldor explores the gap between AI adoption and AI confidence, drawing on findings from the Researcher of the Future report

7 min read

Cell & Gene Development & Clinical Research News

This Week's CGT News: First Treg Therapy Approved

July 7, 2026

First Treg-based cell therapy approved, FDA advanced therapy office faces fresh turnover, and preclinical CAR T studies target rare blood cancers and glioblastoma

5 min read

Cell & Gene Business & Trends

Roving Reporter Asks: How Are CGT Companies Rethinking Pricing and Reimbursement?

July 7, 2026

IBTV speaks with industry leaders at ARM’s Meeting on the Med 2026 to explore how cell and gene therapy companies are approaching pricing, reimbursement, and access as more potentially curative therapies reach patients

1 min read

Cell & Gene Research News Drug Discovery Development & Clinical

AI Framework Helps Identify New CAR T Target

July 6, 2026

A human-in-the-loop AI strategy helped narrow more than 10,000 candidates to a CAR T target now validated in mouse models

2 min read

Small Molecules Facilities & Equipment Interviews Innovation Awards

The Grand Winner

July 6, 2026

IMA Active’s DOMINA has been voted the Grand Winner of The Medicine Maker Innovation Awards 2025

6 min read

Biopharma Development & Clinical Outsourcing Business & Trends

Biopharma Vital Signs – Part 3: Pressure Points

July 3, 2026

From clinical translation and regulatory expectations to manufacturing readiness, capital constraints, and commercial viability, experts identify the pressure points shaping the path from discovery to market

13 min read

Development & Clinical Biopharma

A Singular Approach to Combatting Infectious Disease

July 2, 2026

How single-cell analysis is evolving to improve vaccine development

4 min read

Bioprocessing Interviews Regulation & Standards Standards & Regulation Quality & Compliance Technology & Manufacturing Sponsored

Moving Beyond Document-Based Validation

July 2, 2026

How UCB is improving traceability, audit readiness, and visibility.

1 min read

Cell & Gene Drug Discovery Development & Clinical Research News

CAR T Cells Target TNF in Mouse Model of Rheumatoid Arthritis

June 30, 2026

A single infusion of engineered T cells degraded soluble TNF and produced durable disease control in mice

2 min read

Cell & Gene Industry News Research News

This Week's CGT News: World's First Solid Tumor CAR T Approved in China

June 30, 2026

5 min read

Top Stories